Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Thomas Quaschning

Showing results (1-10 of 24) with videos related to

Pageof 3
Sort By:
Current Pharmaceutical Design|October 28, 2005
Vasopeptidase inhibition for blood pressure control: emerging experienceThomas Quaschning
Kidney International. Supplement|April 16, 2003
Vasopeptidase inhibition: a new treatment approach for endothelial dysfunctionThomas Quaschning, Jan Galle, Christoph Wanner
Current Hypertension Reports|January 16, 2002
Vasopeptidase inhibition: effective blood pressure control for vascular protectionThomas Quaschning, Frank Ruschitzka, Thomas F Lüscher
Kidney & Blood Pressure Research|June 22, 2011
Chronic renal failure and its complicationsVladimir Tesař, Christoph Wanner, Thomas Quaschning, et al.
Kidney International. Supplement|April 16, 2003
Endothelial dysfunction and inflammation: what is the link?Jan Galle, Thomas Quaschning, Stefan Seibold, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|August 5, 2005
Impact of pre-transplant anaemia correction and erythropoietin resistance on long-term graft survivalMariarosaria Campise, Ashraf Mikhail, Thomas Quaschning, et al.
Hypertension (Dallas, Tex. : 1979)|February 24, 2001
Vasopeptidase Inhibition Prevents Endothelial Dysfunction of Resistance Arteries in Salt-Sensitive Hypertension in Comparison With Single ACE InhibitionLivius V. d'Uscio, Thomas Quaschning, John C. Burnett, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|February 14, 2003
Increase in nitric oxide bioavailability improves endothelial function in endothelin-1 transgenic miceThomas Quaschning, Serkan Koçak, Christian Bauer, et al.
The Journal of Biological Chemistry|August 6, 2003
Regulation of vascular tone in animals overexpressing the sarcolemmal calcium pumpKai Schuh, Thomas Quaschning, Sebastian Knauer, et al.
Clinical Chemistry and Laboratory Medicine|April 19, 2007
A novel frameshift mutation of the lecithin:cholesterol acyltransferase (LCAT) gene associated with renal failure in familial LCAT deficiencyBernhard U Bender, Thomas Quaschning, Hartmut P H Neumann, et al.
Pageof 3

Showing results (1-10 of 24) with videos related to

Sort By:
Pageof 3
Current Pharmaceutical Design|October 28, 2005
Vasopeptidase inhibition for blood pressure control: emerging experienceThomas Quaschning
Kidney International. Supplement|April 16, 2003
Vasopeptidase inhibition: a new treatment approach for endothelial dysfunctionThomas Quaschning, Jan Galle, Christoph Wanner
Current Hypertension Reports|January 16, 2002
Vasopeptidase inhibition: effective blood pressure control for vascular protectionThomas Quaschning, Frank Ruschitzka, Thomas F Lüscher
Kidney & Blood Pressure Research|June 22, 2011
Chronic renal failure and its complicationsVladimir Tesař, Christoph Wanner, Thomas Quaschning, et al.
Kidney International. Supplement|April 16, 2003
Endothelial dysfunction and inflammation: what is the link?Jan Galle, Thomas Quaschning, Stefan Seibold, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|August 5, 2005
Impact of pre-transplant anaemia correction and erythropoietin resistance on long-term graft survivalMariarosaria Campise, Ashraf Mikhail, Thomas Quaschning, et al.
Hypertension (Dallas, Tex. : 1979)|February 24, 2001
Vasopeptidase Inhibition Prevents Endothelial Dysfunction of Resistance Arteries in Salt-Sensitive Hypertension in Comparison With Single ACE InhibitionLivius V. d'Uscio, Thomas Quaschning, John C. Burnett, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|February 14, 2003
Increase in nitric oxide bioavailability improves endothelial function in endothelin-1 transgenic miceThomas Quaschning, Serkan Koçak, Christian Bauer, et al.
The Journal of Biological Chemistry|August 6, 2003
Regulation of vascular tone in animals overexpressing the sarcolemmal calcium pumpKai Schuh, Thomas Quaschning, Sebastian Knauer, et al.
Clinical Chemistry and Laboratory Medicine|April 19, 2007
A novel frameshift mutation of the lecithin:cholesterol acyltransferase (LCAT) gene associated with renal failure in familial LCAT deficiencyBernhard U Bender, Thomas Quaschning, Hartmut P H Neumann, et al.
Pageof 3